Modulatory Effects of Dietary Amino Acids on Neurodegenerative Diseases

Author(s):  
Senthilkumar Rajagopal ◽  
Supraj Raja Sangam ◽  
Shubham Singh ◽  
Venkateswara Rao Joginapally
2020 ◽  
Vol 21 (8) ◽  
pp. 785-798 ◽  
Author(s):  
Abedin Abdallah ◽  
Evera Elemba ◽  
Qingzhen Zhong ◽  
Zewei Sun

The gastrointestinal tract (GIT) of humans and animals is host to a complex community of different microorganisms whose activities significantly influence host nutrition and health through enhanced metabolic capabilities, protection against pathogens, and regulation of the gastrointestinal development and immune system. New molecular technologies and concepts have revealed distinct interactions between the gut microbiota and dietary amino acids (AAs) especially in relation to AA metabolism and utilization in resident bacteria in the digestive tract, and these interactions may play significant roles in host nutrition and health as well as the efficiency of dietary AA supplementation. After the protein is digested and AAs and peptides are absorbed in the small intestine, significant levels of endogenous and exogenous nitrogenous compounds enter the large intestine through the ileocaecal junction. Once they move in the colonic lumen, these compounds are not markedly absorbed by the large intestinal mucosa, but undergo intense proteolysis by colonic microbiota leading to the release of peptides and AAs and result in the production of numerous bacterial metabolites such as ammonia, amines, short-chain fatty acids (SCFAs), branched-chain fatty acids (BCFAs), hydrogen sulfide, organic acids, and phenols. These metabolites influence various signaling pathways in epithelial cells, regulate the mucosal immune system in the host, and modulate gene expression of bacteria which results in the synthesis of enzymes associated with AA metabolism. This review aims to summarize the current literature relating to how the interactions between dietary amino acids and gut microbiota may promote host nutrition and health.


Amino Acids ◽  
2014 ◽  
Vol 46 (11) ◽  
pp. 2489-2501 ◽  
Author(s):  
Yu-Xiang Yang ◽  
Zhao-Lai Dai ◽  
Wei-Yun Zhu

2021 ◽  
Vol 22 (16) ◽  
pp. 8677
Author(s):  
Nunzianna Doti ◽  
Mario Mardirossian ◽  
Annamaria Sandomenico ◽  
Menotti Ruvo ◽  
Andrea Caporale

Natural and de novo designed peptides are gaining an ever-growing interest as drugs against several diseases. Their use is however limited by the intrinsic low bioavailability and poor stability. To overcome these issues retro-inverso analogues have been investigated for decades as more stable surrogates of peptides composed of natural amino acids. Retro-inverso peptides possess reversed sequences and chirality compared to the parent molecules maintaining at the same time an identical array of side chains and in some cases similar structure. The inverted chirality renders them less prone to degradation by endogenous proteases conferring enhanced half-lives and an increased potential as new drugs. However, given their general incapability to adopt the 3D structure of the parent peptides their application should be careful evaluated and investigated case by case. Here, we review the application of retro-inverso peptides in anticancer therapies, in immunology, in neurodegenerative diseases, and as antimicrobials, analyzing pros and cons of this interesting subclass of molecules.


2003 ◽  
Vol 1 (1) ◽  
pp. 1-5 ◽  
Author(s):  
André Nieoullon ◽  
Laurence Had-Aissouni ◽  
Lydia Kerkerian-Le Goff

Author(s):  
Reeta Rintamäki ◽  
Timo Partonen

Sign in / Sign up

Export Citation Format

Share Document